Shigeharu Nakano

Kyoto University

Japan

Research Interests

Explore related searches

Professors in Japan Professors in Cancer Biology Cancer Biology professors in Japan

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (8)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2020

Collaborators (3)

Yuji Eso

Assistant professor

Kyoto Prefectural University of Medicine

JAPAN

View details

Atsushi Takai

Kyoto University

JAPAN

View details

Haruhiko Takeda

Kyoto University Hospital

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Shigeharu Nakano

Research Interests

Explore related searches

Contact this professor

Articles (8)

Acquisition Process and Clinical Relevance of dMMR-Associated Mutational Signatures in Hepatocellular Carcinoma.

Publisher Correction: CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.

TERT upregulation promotes cell proliferation via degradation of p21 and increases carcinogenic potential.

CRAFITY score as a predictive marker for refractoriness to atezolizumab plus bevacizumab therapy in hepatocellular carcinoma: a multicenter retrospective study.

A Rare Case of Donor-Origin Intrahepatic Cholangiocarcinoma After Liver Transplantation for Hepatocellular Carcinoma: A Case Report.

Mac-2 binding protein glycosylation isomer predicts tolerability and clinical outcome of lenvatinib therapy for hepatocellular carcinoma.

A simplified method to quantitatively predict the effect of lenvatinib on hepatocellular carcinoma using contrast-enhanced ultrasound with perfluorobutane microbubbles.

Recent Advances in Immunotherapy for Hepatocellular Carcinoma

Collaborators (3)

Yuji Eso

Atsushi Takai

Haruhiko Takeda

Make your next move.